序号 |
标题 |
次数 |
作者 |
发布时间 |
74566 |
DOTA-Leu-Gly-Glu-Tyr-Gly-Phe-Gln-Asn-Ala-Leu-Ile-V |
102 |
h |
2024-12-17 |
74567 |
PEG114-b-P4VP107, 聚乙二醇-b-聚(4-乙烯基吡啶),烷基链定制 |
104 |
wyh |
2024-12-17 |
74568 |
NH2-PEG4-DOTA-GA,CAS:137076-54-1 |
76 |
h |
2024-12-17 |
74569 |
99mTc-HYNIC-lys(Cy5.5)-PEG4-biotin 新型双模态探针 |
116 |
zyl |
2024-12-17 |
74570 |
cas:448954-98-1,HBr.H2N-O-(CH2)5-COOH, 6-氨基氧基己酸氢溴酸盐 |
72 |
kx |
2024-12-17 |
74571 |
马来酰亚胺修饰的大环配体Maleimide-DTPA |
87 |
h |
2024-12-17 |
74572 |
DOTA-3-酪氨酰基-奥曲肽,177943-89-4 |
61 |
h |
2024-12-17 |
74573 |
mPEG5-NHMe的介绍 |
83 |
zyl |
2024-12-17 |
74574 |
过表达质粒转染的原理和步骤 |
757 |
axc |
2024-12-17 |
74575 |
二聚体荧光探针(TMTP1-PEG4)2-ICG-定制 |
99 |
zyl |
2024-12-17 |
74576 |
DOTA-cyclo(RGDfK)acetate,909024-55-1 |
82 |
h |
2024-12-17 |
74577 |
MAG3-PEG8-c(RGDYK),烷基链定制 |
106 |
wyh |
2024-12-17 |
74578 |
mPEG113-b-P(MTC-Chol11)-定制 |
80 |
zyl |
2024-12-17 |
74579 |
DOTA-Peptide C105Y;DOTA偶联Peptide C105Y |
74 |
h |
2024-12-17 |
74580 |
靶向Nectin-4的抗体药物偶联物,烷基链定制 |
150 |
wyh |
2024-12-17 |
74581 |
DOTA-RGD-4C,DOTA偶联RGD-4C |
78 |
h |
2024-12-17 |
74582 |
靶向EGFR的抗体药物偶联物(EGFR-ADC)-定制 |
114 |
zyl |
2024-12-17 |
74583 |
DOTA-MAP;DOTA偶联细胞穿膜肽MAP |
75 |
h |
2024-12-17 |
74584 |
DOTA偶联PH响应性细胞穿膜肽TH |
87 |
h |
2024-12-17 |
74585 |
抗体药物偶联物的药物-连接子MC-MMAF-定制服务 |
116 |
zyl |
2024-12-17 |
74586 |
抗cMet抗体药物偶联物,烷基链定制 |
140 |
wyh |
2024-12-17 |
74587 |
DOTA-PT;大环配体-PT多肽 |
81 |
h |
2024-12-17 |
74588 |
MC-VC-PAB-PNP,ADC肽类连接子,烷基链定制 |
155 |
wyh |
2024-12-17 |
74589 |
DOTA-(D-Gln)3-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 |
85 |
h |
2024-12-17 |
74590 |
DOTA-SP0104;大环配体-SP0104多肽 |
138 |
h |
2024-12-17 |
74591 |
MC-Val-Cit-PAB-DOX,Doxorubicin-MVCP,烷基链定制 |
126 |
wyh |
2024-12-17 |
74592 |
DOTA-三叔丁酯活性酯,DOTA-(COOt-Bu)3-NHS,CAS:819869-77-7 |
155 |
h |
2024-12-17 |
74593 |
DOTA-(COOt-Bu)3-butyne,丁炔-DOTA-三(叔丁基酯) |
129 |
h |
2024-12-17 |
74594 |
MC-Val-Cit-PAB,抗体-药物缀合物,烷基链定制 |
83 |
wyh |
2024-12-17 |
74595 |
RNA干扰实现基因敲减,技术详情 |
190 |
axc |
2024-12-17 |
74596 |
FolA-PEG24-K(Stp4-C)2,烷基链定制 |
76 |
wyh |
2024-12-17 |
74597 |
Fab-PEG(24)-EGF, 曲妥珠单抗聚乙二醇偶联表皮生长因子,烷基链定制 |
145 |
wyh |
2024-12-17 |
74598 |
DOTA-TOC,DOTA-[Tyr3]-Octreotide,Edotreotide |
97 |
h |
2024-12-17 |
74599 |
聚吡咯-聚乙二醇24 PPY-PEG24,烷基链定制 |
95 |
wyh |
2024-12-17 |
74600 |
双功能螯合剂THP(Bz)3-NH2,CAS:827331-42-0 |
121 |
h |
2024-12-17 |
74601 |
NOTA-(COOt-Bu)2-Butyne,NO2A-丁炔-二叔丁酯 |
117 |
h |
2024-12-17 |
74602 |
Mal-PtBA20-b-PEG23,烷基链定制 |
131 |
wyh |
2024-12-17 |
74603 |
p-NH2-Bn-DOTA-tetra(t-Bu ester) |
89 |
h |
2024-12-17 |
74604 |
NHS-PEG18-PDP,N-羟基琥珀酰亚胺-十八聚乙二醇-PDP,烷基链定制 |
138 |
wyh |
2024-12-17 |
74605 |
Gd-DOTA-TPP,TPP-Lys(Acp-DOTA-Gd)-COOH |
77 |
h |
2024-12-17 |
74606 |
biotin-PEG12-peptide ,生物素-十二聚乙二醇-磷酸化环腺苷酸应答元件结合蛋白(多肽),烷基链定制 |
66 |
wyh |
2024-12-17 |
74607 |
DOTA-NOC acetate,CAS:619300-53-7 |
73 |
h |
2024-12-17 |
74608 |
cFLFLF-(PEG)12-TKPPR,烷基链定制 |
126 |
wyh |
2024-12-17 |
74609 |
聚乙二醇化干扰素α2b (IFN-PEG12,31kDa),烷基链定制 |
88 |
wyh |
2024-12-17 |
74610 |
ATF24多肽修饰的β-榄香烯脂质体 ATF24-PEG-Lipo-β-E |
144 |
zyl |
2024-12-17 |